Kellen Choi, DO
Urology · Louisville, KYNPI 1184915373
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,800 of the $17,246 with a category attached, or 62.6%. Gyrus ACMI, Inc. accounts for 62.6% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2020 at $10,970 and has fallen 78.8% since, to $2,322 in 2025. Among urology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 180 payments — averaging $95.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gyrus ACMI, Inc.$11K
- Teleflex LLC$2K
- Medtronic$2K
- Astellas Pharma US Inc$477
- Coloplast$298
- Boston Scientific$190
- plus $1K from 25 others
What the payments were for
- Consulting fees$10,80063%
- Travel & lodging$1,90111%
- Food & beverage$4,24325%
- Education$3032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gyrus ACMI, Inc. | 2 | $10,800 |
| Teleflex LLC | 17 | $2,481 |
| Medtronic(2 entities) | 75 | $1,709 |
| Astellas Pharma US Inc | 17 | $477 |
| Coloplast | 8 | $298 |
| Boston Scientific | 4 | $190 |
| Axonics, Inc. | 9 | $157 |
| Intuitive Surgical | 2 | $145 |
| Sumitomo Pharma America, Inc. | 6 | $119 |
| AbbVie(2 entities) | 5 | $97 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $81 |
| Hollister Incorporated | 3 | $71 |
| Blue Earth Diagnostics | 3 | $62 |
| Dentsply IH AB | 2 | $58 |
| Laborie Medical Technologies Corp. | 3 | $52 |
| Smith+Nephew | 1 | $49 |
| Rochester Medical Corporation | 2 | $48 |
| Olympus America Inc. | 2 | $46 |
| Agiliti Surgical, Inc. | 2 | $45 |
| KARL Storz Endoscopy-america | 1 | $43 |
| ABC Home Medical Supply, Inc. | 2 | $32 |
| Johnson & Johnson | 2 | $29 |
| Endo Pharmaceuticals Inc. | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Urovant Sciences Inc | 1 | $19 |
| 180 Medical, Inc. | 1 | $18 |
| Seagen Inc. | 1 | $18 |
| Halozyme Inc | 1 | $14 |
| Koelis Inc. | 1 | $14 |
| Sagent Pharmaceuticals | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UGN Laser Capital$10,800
- UroLift$2,167
- Barrigel$1,256
- INTERSTIM$819
- AMS$113
How this compares
$17,246 in reported general payments places this provider in the 90th percentile of 139 urology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 233 | $138,137 |
| MyrbetriqMirabegron | 42 | $22,991 |
| Trimethoprim | 21 | $597 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 46 | $547 |
| NitrofurantoinNitrofurantoin Macrocrystal | 31 | $469 |
| Tamsulosin Hcl | 51 | $312 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $303 |
| Cephalexin | 51 | $251 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $219 |
| Estradiol | 11 | $206 |
| Finasteride | 31 | $73 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $119 | $138,137233 claims |
| Astellas Pharma US IncMyrbetriq | $477 | $22,99142 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 139 urology providers in Kentucky.
Other urology in Louisville
- Uzoma AneleLouisville$60K
- Rosa ParkLouisville$16K
- Mohammed SaidLouisville$11K
- Terrance BlackfordLouisville$10K
- Jessica SchardeinLouisville$9K
- Jonathan WittenLouisville$9K
- Morris JacksonLouisville$7K
- Thomas SlabaughLexington$102K
- Lee EvansHopkinsville$56K
- Patrick HensleyLexington$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.